The Big ReadLongevity Treatments for a 91-Year-Old? A Bold Bet in Silicon Valley’s Immortality Race
In Silicon Valley, some quests for the fountain of youth have most definitely won the backing of tech’s leading names. Sam Altman, OpenAI’s CEO, personally invested $180 million to launch Retro Biosciences, which is working on ways to rejuvenate aging cells. CoinBase’s Brian Armstrong co-founded NewLimit, which has raised over $200 million for a similar pursuit from investors that include Peter Thiel’s Founders Fund. And Jeff Bezos reportedly helped bankroll a startup focused on life...